Distinguished in Hepatitis C

Dr. Mordechai Rabinovitz

Hepatology
UPMC
University Of Pittsburgh Physicians
600 Oxford Dr, Suite 210, 
Monroeville, PA 
Offers Telehealth
48 Years of Experience
Distinguished in Hepatitis C
UPMC
University Of Pittsburgh Physicians
600 Oxford Dr, Suite 210, 
Monroeville, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mordechai Rabinovitz is a Hepatologist in Monroeville, Pennsylvania. Dr. Rabinovitz has been practicing medicine for over 48 years and is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Primary Biliary Cholangitis, Liver Transplant, and Endoscopy.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Hepatitis C.

Specialties
Hepatology
Licenses
Specialist in PA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc St Margaret
Upmc Passavant
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UNIVERSITY OF PITTSBURGH PHYSICIANS
600 Oxford Dr, Suite 210, Monroeville, PA 15146
Call: 412-692-4400
Other Locations
UNIVERSITY OF PITTSBURGH PHYSICIANS
300 Halket St, Pittsburgh, PA 15213
UNIVERSITY OF PITTSBURGH PHYSICIANS
200 Lothrop St, Pittsburgh, PA 15213

Additional Areas of Focus

Dr. Rabinovitz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Enrollment Status: Active_not_recruiting
Publish Date: February 04, 2026
Intervention Type: Drug
Study Drug: Volixibat
Study Phase: Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: HM15211
Study Phase: Phase 2
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
Enrollment Status: Terminated
Publish Date: September 06, 2022
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 4
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
Per-Oral Cholangioscopy in Liver Transplantation Patients
Per-Oral Cholangioscopy in Liver Transplantation Patients
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Device
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Primary Biliary Cholangitis Who Have an Inadequate Response or Are Intolerant to UDCA
Enrollment Status: Terminated
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

17 Total Publications

Natural history of spontaneous pancreatic portal vein fistulae: A systematic review of the literature.
Natural history of spontaneous pancreatic portal vein fistulae: A systematic review of the literature.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: April 23, 2024
View All 17 Publications
Similar Doctors
Distinguished in Hepatitis C
Dr. Bennet Cecil
Hepatology
Distinguished in Hepatitis C
Dr. Bennet Cecil
Hepatology
213 U S Hwy 250, 
Adena, OH 
 (58.0 miles away)
502-894-9950
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bennet Cecil is a Hepatologist in Adena, Ohio. Dr. Cecil is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Jaundice, and Visceromegaly.

Distinguished in Hepatitis C
Dr. Obaid Shaikh
Hepatology
Distinguished in Hepatitis C
Dr. Obaid Shaikh
Hepatology

University Of Pittsburgh Physicians

300 Halket St, 
Pittsburgh, PA 
 (9.1 miles away)
Experience:
47+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Obaid Shaikh is a Hepatologist in Pittsburgh, Pennsylvania. Dr. Shaikh has been practicing medicine for over 47 years and is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis, Hepatitis C, Cirrhosis, Alcoholic Cirrhosis, and Liver Transplant.

Advanced in Hepatitis C
Dr. Scott Biggins
Hepatology
Advanced in Hepatitis C
Dr. Scott Biggins
Hepatology

University Of Pittsburgh Physicians

200 Lothrop St, 
Pittsburgh, PA 
 (9.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Scott Biggins is a Hepatologist in Pittsburgh, Pennsylvania. Dr. Biggins is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Ascites, Liver Failure, Spontaneous Bacterial Peritonitis, Hepatorenal Syndrome, and Liver Transplant.

VIEW MORE HEPATITIS C DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rabinovitz's expertise for a condition
ConditionClose
    • Distinguished
    • Budd-Chiari Syndrome
      Dr. Rabinovitz is
      Distinguished
      . Learn about Budd-Chiari Syndrome.
      See more Budd-Chiari Syndrome experts
    • Cirrhosis
      Dr. Rabinovitz is
      Distinguished
      . Learn about Cirrhosis.
      See more Cirrhosis experts
    • Enlarged Liver
      Dr. Rabinovitz is
      Distinguished
      . Learn about Enlarged Liver.
      See more Enlarged Liver experts
    • Hepatitis
      Dr. Rabinovitz is
      Distinguished
      . Learn about Hepatitis.
      See more Hepatitis experts
    • Hepatitis C
      Dr. Rabinovitz is
      Distinguished
      . Learn about Hepatitis C.
      See more Hepatitis C experts
    • Primary Biliary Cholangitis
      Dr. Rabinovitz is
      Distinguished
      . Learn about Primary Biliary Cholangitis.
      See more Primary Biliary Cholangitis experts
    View All 7 Distinguished Conditions
    • Advanced
    • Alcoholic Cirrhosis
      Dr. Rabinovitz is
      Advanced
      . Learn about Alcoholic Cirrhosis.
      See more Alcoholic Cirrhosis experts
    • Ascites
      Dr. Rabinovitz is
      Advanced
      . Learn about Ascites.
      See more Ascites experts
    • Autoimmune Hepatitis
      Dr. Rabinovitz is
      Advanced
      . Learn about Autoimmune Hepatitis.
      See more Autoimmune Hepatitis experts
    • Banti's Syndrome
      Dr. Rabinovitz is
      Advanced
      . Learn about Banti's Syndrome.
      See more Banti's Syndrome experts
    • Cholangitis
      Dr. Rabinovitz is
      Advanced
      . Learn about Cholangitis.
      See more Cholangitis experts
    • Esophageal Varices
      Dr. Rabinovitz is
      Advanced
      . Learn about Esophageal Varices.
      See more Esophageal Varices experts
    View All 13 Advanced Conditions
    • Experienced
    • Alpha-1 Antitrypsin Deficiency (AATD)
      Dr. Rabinovitz is
      Experienced
      . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
      See more Alpha-1 Antitrypsin Deficiency (AATD) experts
    • Caroli Disease
      Dr. Rabinovitz is
      Experienced
      . Learn about Caroli Disease.
      See more Caroli Disease experts
    • Congenital Hepatic Fibrosis
      Dr. Rabinovitz is
      Experienced
      . Learn about Congenital Hepatic Fibrosis.
      See more Congenital Hepatic Fibrosis experts
    • Endoscopy
      Dr. Rabinovitz is
      Experienced
      . Learn about Endoscopy.
      See more Endoscopy experts
    • Fibrolamellar Carcinoma
      Dr. Rabinovitz is
      Experienced
      . Learn about Fibrolamellar Carcinoma.
      See more Fibrolamellar Carcinoma experts
    • Gallbladder Adenocarcinoma
      Dr. Rabinovitz is
      Experienced
      . Learn about Gallbladder Adenocarcinoma.
      See more Gallbladder Adenocarcinoma experts
    View All 18 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.